Considering returns on federal investment in the negotiated "maximum fair price" of drugs under the Inflation Reduction Act : an analysis

Edward W. Zhou, Paula G. Chaves da Silva, Debbie Quijada, and Fred D. Ledley

Year of publication:	[2024]
Authors:	Zhou, Edward W. ; Silva, Paula G. Chaves da ; Quijada, Debbie ; Ledley, Fred D.
Publisher:	New York, NY : Institute for New Economic Thinking
Subject:	Inflation Reduction Act \| drug pricing \| Medicare \| federal funding \| biomedical research \| health value \| social return on investment \| Arzneimittel \| Pharmaceuticals \| Inflation \| Gesundheitskosten \| Health care costs \| Inflationsbekämpfung \| Anti-inflation policy

freely available

Full text |

More access options

doi.org

ideas.repec.org

Check Google Scholar

In German libraries (KVK)

Which error do you want to report?

Report: URL of this record is broken

Please note: Sometimes more than one URL is available for a resource. Please click on "More Options" to display these URLs

Report: Addition of an URL to that resource

Please note: Sometimes more than one URL is available for a resource. Please click on "More Options" to display these URLs

Report: The language(s) of that resource is/are…

Please note: Required language not in the list? Please use comment field

Report: Addition of an identifier to that resource

Report: report typo

Report: Add statement

Report: Add keywords

Please use the commentary box to describe other errors

Would you like to receive a feedback?

Commentary

Please type the code from the image

For general questions please use this address.

Persistent link: https://www.econbiz.de/10015097593

A service of the